All news

Radiopharm Theranostics breaches ASX listing rule on director issues

Alpha Vantage · Kalkine Media · · AI-summarised by FinFlash

Radiopharm Theranostics (ASX:RAD) breached ASX Listing Rule 10.11 after issuing more shares and options to four directors than shareholders approved, because the Share Purchase Plan offer price was set below the maximum price in the resolutions. The company will sell 4,888,889 excess shares, donate proceeds to charity, and cancel an equal number of excess options.

Read original source

RADX company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.